330 – Autism, ADHD, and Anxiety: the rise in autism & an approach to diagnosing & treating children
Peter Attia MDKey Moments
Pediatrician discusses autism, ADHD, anxiety in children: diagnosis, causes, treatment, and the importance of personalized, multidisciplinary care.
Key Insights
Diagnoses like autism, ADHD, and anxiety are clinical, based on observed traits and functional impairment, not biomarkers.
The definition and scope of autism diagnoses have broadened, particularly with the DSM-5, leading to increased reported prevalence.
Autism is highly heritable (up to 98%) but also influenced by complex gene-environment interactions and epigenetics.
Overlapping diagnoses are common, with many children exhibiting traits of autism, ADHD, and anxiety concurrently.
Effective treatment requires personalized, multidisciplinary approaches considering biological, psychological, and social factors, with a strong emphasis on family involvement.
ABA therapy, while controversial, can be a valuable tool when applied naturalistically and with well-trained professionals.
DIAGNOSTIC APPROACHES FOR BEHAVIORAL CONDITIONS
Developmental behavioral pediatrician Trenna Sutcliffe emphasizes that diagnoses like anxiety, ADHD, and autism are clinical, relying on checklists of traits and observed functional impairment rather than biological markers such as blood tests or brain scans. A key criterion for any diagnosis is whether the traits cause significant impairment in a child's daily functioning, such as in school, social interactions, or self-esteem. Clinicians must have extensive experience to interpret these traits within the context of the child's life and the DSM-5 criteria, recognizing that neurobiology is far more complex than simple diagnostic boxes.
AGE RANGES FOR DIAGNOSIS AND IMPAIRMENT AS A KEY FACTOR
The earliest age a diagnosis can be confidently made varies: for autism, it's as young as 18 months, though often closely monitored; for ADHD, it's typically around four years old, but often diagnosed closer to school age (five to six) to better assess functional impact; and various anxiety conditions can be identified in preschoolers. The concept of impairment is crucial, distinguishing normal childhood behaviors from those that significantly hinder a child's ability to learn, form relationships, and engage in their community, which directly impacts their self-esteem and overall development.
ADDRESSING THE SPECTRUM OF AUTISM
Autism Spectrum Disorder (ASD) encompasses a wide range of presentations, from non-verbal individuals with significant communication challenges to those with strong language skills who struggle with social reciprocity and have restricted interests. The DSM-5, introduced in 2013, broadened the diagnostic umbrella by integrating previous diagnoses like Asperger's syndrome and PDD-NOS under ASD. This expansion, along with increased awareness and more clinicians making diagnoses, contributes to the reported rise in prevalence, though the field also suspects underlying environmental and epigenetic factors play a role.
THE COMPLEX CAUSES OF AUTISM: GENETICS AND ENVIRONMENT
The heritability of autism is exceptionally high, estimated between 70% to 98%, suggesting a strong genetic component involving multiple genes. However, it's not attributed to a single gene. The 'multiple hits' model suggests autism arises from a complex interplay of genetics, environmental factors (such as maternal infection, stress, pollution, and parental age), and epigenetics – changes in gene expression that can potentially be passed down through generations. Research is ongoing to fully unravel these intricate causal pathways.
OVERLAP AND TREATMENT STRATEGIES FOR NEURODEVELOPMENTAL CONDITIONS
Significant overlap exists between autism, ADHD, and anxiety, with about half of children with autism also having ADHD and around 40% experiencing anxiety. Many may present with all three. For ADHD, anxiety or mood disorders are common comorbidities. Oppositional behaviors are often a symptom of an underlying issue like anxiety, impulsivity, sensory overload, or social communication deficits, rather than a standalone disorder. Treatment plans must be personalized, considering the 'why' behind the behavior and incorporating biological (medication), psychological (therapy), and social (family, school) factors.
THE ROLE OF MEDICATION AND THERAPEUTIC INTERVENTIONS
Stimulant medications (methylphenidate and amphetamine-based) are first-line treatments for ADHD, often combined with behavioral parent training, especially for children aged six and older. Non-stimulants and older blood pressure medications are also used. While there are risks, the potential benefits for academic success and long-term adjustment are significant. For autism, medications target specific symptoms like hyperactivity, anxiety, or rigidity, rather than core features. Therapeutic interventions, including ABA, parent training, and social skills groups, are crucial for developing adaptive behaviors and supporting the child's development. Early intervention and a multidisciplinary team approach are key to positive outcomes.
EMPOWERING FAMILIES AND NAVIGATING THE SYSTEM
Finding effective care can be challenging, especially outside major metropolitan areas. Sutcliffe advises parents to start with their pediatrician and seek a multidisciplinary team that emphasizes personalized care and collaboration with schools. Key indicators of a good provider include a flexible, individualized approach, a willingness to collaborate with other professionals, and strong parent-training components. The goal is not just diagnosis but empowering families with a roadmap and strategies to support their child's well-being and development.
THE IMPORTANCE OF THE BIOCYCHOSOCIAL MODEL AND PERSONALIZED CARE
Developmental Behavioral Pediatrics (DBP), a relatively young specialty, uniquely adopts a biopsychosocial model, considering biological factors (genetics, brain development, medication), psychological aspects (mental health, emotion regulation), and social influences (family dynamics, school environment, community). This holistic view is essential for supporting child development and well-being. Sutcliffe's own clinic reflects this philosophy, moving away from a disease-focused model to one that prioritizes health promotion, integrated multidisciplinary teams, community collaboration, and a family-centric approach, underscoring that personalized care is paramount for making a genuine difference.
Mentioned in This Episode
●Organizations
●Books
●Concepts
●People Referenced
Common Questions
Autism can be confidently diagnosed as young as 18 months, though typically it's diagnosed around three or four years of age. ADHD can technically be diagnosed at four, but clinicians often wait until school age (five to six). Anxiety conditions, including separation anxiety and selective mutism, can be seen in preschoolers.
Topics
Mentioned in this video
A hospital in Toronto where Dr. Kang completed her DBP training.
Another stimulant medication in the methylphenidate class, used for ADHD, with an extended-release mechanism.
A pro-drug in the amphetamine class used for ADHD, which requires metabolic cleavage to become active.
A previous diagnostic label for individuals who had some autism-like traits but did not meet full criteria for autistic disorder; now part of ASD.
A stimulant medication used for ADHD, part of the methylphenidate class, available in various formulations with different release mechanisms.
A previous diagnostic label for individuals with autism-like traits but preserved cognitive and language skills, which was subsumed under ASD in the DSM-5.
An SSRI medication mentioned as an example, potentially used for anxiety or rigidity in children with autism.
An SSRI medication mentioned as an example, potentially used for anxiety or rigidity in children with autism.
Guest on the podcast, a developmental behavioral pediatrician, trained in genetics, pediatrics, and pediatric neurology, who later founded her own multi-disciplinary clinic in the Bay Area.
A naturalistic form of ABA that trains parents to teach skills in a child's natural environment using their natural motivators.
A behavioral intervention used with children, traditionally with autism, that breaks down skills into smaller subsets using repetitive, adult-directed methods. It is now evolving into more naturalistic forms.
A stimulant medication in the methylphenidate class, used for ADHD, noted for differing responses compared to other methylphenidate brands based on release mechanisms.
A stimulant medication, part of the amphetamine class, used for ADHD, known since the 1930s.
The current diagnostic term for autism, established in 2013 with the DSM-5, encompassing a wide range of manifestations and replacing previous labels like Asperger Syndrome.
Recognized Developmental Behavioral Pediatrics as a subspecialty in 1999.
An incredible developmental pediatrician who created the division of DBP at Stanford after Dr. Kang's initial pioneer work there.
An older, more structured and repetitive form of ABA where a child learns a skill through repeated trials and positive reinforcement.
A stimulant medication in the amphetamine class used for ADHD.
A non-stimulant medication for ADHD that increases norepinephrine levels in synapses.
An alpha-2 agonist blood pressure medication also used as a non-stimulant for ADHD, acting on ion channels in neurons.
An alpha-2 agonist blood pressure medication also used as a non-stimulant for ADHD, acting on ion channels in neurons.
More from Peter Attia MD
View all 104 summaries
135 min381‒Alzheimer’s disease in women: how hormonal transitions impact the brain, new therapies, & more
9 minIs Industrial Processing the Real Problem With Seed Oils? | Layne Norton, Ph.D.
13 minCooking with Lard vs Seed Oils | Layne Norton, Ph.D.
146 min380 ‒ The seed oil debate: are they uniquely harmful relative to other dietary fats?
Found this useful? Build your knowledge library
Get AI-powered summaries of any YouTube video, podcast, or article in seconds. Save them to your personal pods and access them anytime.
Try Summify free